Long-term treatment with the drug upadacitinib significantly improved symptoms and quality of life compared to placebo in adolescents with moderate to severe atopic dermatitis after 76 weeks with strong evidence of safety, according to a recent Northwestern Medicine analysis of three international, randomized clinical trials.
Just two years out from its launch, the Center for Human Immunobiology has quickly become a bustling hub for collaborative efforts to understand the molecular mechanisms of the immune system and translate discoveries into innovative cures for immune-regulated diseases.
A Northwestern University-led team of engineers has developed a new type of wearable device that stimulates skin to deliver various complex sensations, providing more realistic and immersive sensory experiences.
Northwestern scientists, clinicians, and members of the ALS community gathered in the Feinberg Pavilion for the 14th annual Les Turner Symposium on ALS to celebrate progress and share the latest research in hopes of better understanding and treating the disease.
In research published in Science Advances, scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington’s disease, an incurable, debilitating illness that causes nerve cells to break down in the brain.
By applying a sophisticated machine-learning approach to electronic health records of patients with pneumonia, investigators at Northwestern University have uncovered five distinct clinical states in pneumonia.
Within a few days of injury, scientists can predict which patients will develop chronic pain based on the extent of cross “talk” between two regions of the brain, and the person’s anxiety level after the injury, according to a new Northwestern study.
A team of scientists led by Northwestern Medicine investigators has created an implant capable of stopping an opioid overdose, according to findings published in Science Advances.
The number of pediatric inpatient psychiatric beds has not risen to meet demand amid a growing youth mental health crisis, according to a Northwestern Medicine-led study published in JAMA Pediatrics.
Treatment with endovascular thrombectomy did not significantly improve outcomes after 90 days in patients with a large core stroke, as compared to patients who received standard stroke care alone, according to a recent clinical trial published in JAMA.